March 16, 2016
What if you could make it easier to find breast cancer in your patients, just by having them take a pill? That's the tantalizing idea behind an animal study presented by University of Michigan researchers on March 15 at the American Chemical Society meeting in San Diego.
Greg Thurber, PhD, and colleagues have developed a near-infrared imaging agent that can be delivered orally in pill form. The agent binds to cancer cells or blood vessels unique to tumors, releasing a dye that fluoresces under near-infrared light.